$188.5 Million

PROCEPT BioRobotics Corporation

Initial Public Offering

Co-Manager, September 2021

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH).